Inici › Càncer de bufeta › Texas › Austin
Assaigs clínics de Càncer de bufeta a Austin, TX
12 estudis de Càncer de bufeta busquen participants en centres de Austin i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
ReclutantFase 2
- Texas Oncology-Austin Central ( Site 0107), Austin
- Urology Austin, PLLC ( Site 0109), Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
ReclutantFase 3
- Texas Oncology, Austin
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
ReclutantFase 1/2
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutantFase 3
- USO-Texas Oncology-Central/South Texas, Austin
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
ReclutantFase 1/2
- Texas Oncology (Balcones) - SCRI, Austin
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
ReclutantFase 1/2
- Urology Austin, PLLC ( Site 0008), Austin
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
ReclutantFase 2
- Urology Austin, PLLC (Urology America), Austin
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
ReclutantFase 2
- Urology Austin, LLC, Austin
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
ReclutantFase 1/2
- Urology Austin, Austin
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
ReclutantFase 2/3
- Local Institution - 0187, Austin
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Reclutant
- Austin Urology Institute, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Elligo Health Research, Inc., Austin
Assaigs de Càncer de bufeta en altres ciutats
- New York City, NY35 estudis
- Nashville, TN31 estudis
- Houston, TX31 estudis
- Dallas, TX27 estudis
- Boston, MA26 estudis
- Washington, DC26 estudis
- Los Angeles, CA24 estudis
- Baltimore, MD24 estudis
- St. Louis, MO22 estudis
- Philadelphia, PA21 estudis
- Seattle, WA21 estudis
- Edison, NJ21 estudis
Altres estudis a Austin
- Càncer de pulmó de cèl·lules no petites30 estudis
- Càncer (tots els tipus)20 estudis
- Obesitat20 estudis
- Càncer metastàtic19 estudis
- Càncer colorrectal19 estudis
- Insuficiència cardíaca18 estudis
- Càncer de mama18 estudis
- Sobrepès18 estudis
- Càncer d'ovari17 estudis
- Càncer d'endometri15 estudis
- Càncer de pròstata15 estudis
- Depressió14 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.